ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Names & News

Pasi A. Janne, MD, PhD

on: June 01, 2018In: Names & News
Pasi A. Janne, MD, PhD

Posted: June 2018 Pasi A. Janne, MD, PhD, was awarded the Second AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award is given to […] Read more


Primo N. Lara, Jr., MD

on: June 01, 2018In: Names & News
Primo N. Lara, Jr., MD

Posted: June 2018 Primo N. Lara, Jr., MD, has been named director of the National Cancer Institute–designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists […] Read more

Laurie E. Gaspar, MD, MBA

on: February 19, 2018In: Names & News
Laurie E. Gaspar, MD, MBA

Posted: February 2018 Laurie E. Gaspar, MD, MBA, has been elected as the 2019- 2020 Treasurer of ASCO. Dr. Gaspar is Professor Emeritus in the Department of Radiation Oncology at […] Read more

Paolo Paoletti, MD

on: February 19, 2018In: Names & News
Paolo Paoletti, MD

New IASLC Foundation Board Member Posted: February 2018 Dr. Paoletti is the Chairman of the Board for Genmab, PsiOxus Therapeutics (Chairman of the Board), FORMA Therapeutics, and Nucana Biomed. He […] Read more

Howard A. “Skip” Burris III, MD

on: February 19, 2018In: Names & News
Howard A. “Skip” Burris III, MD

Posted: February 2018 Howard A. “Skip” Burris III, MD, has been elected to serve as the 2019-2020 President of the American Society of Clinical Oncology (ASCO) for the term beginning […] Read more

Bruce Ratner

on: February 19, 2018In: Names & News
Bruce Ratner

New IASLC Foundation Board Member Posted: February 2018 Mr. Ratner is the Executive Chairman of Forest City Ratner Cos., a New York-based real estate development company, which he started in […] Read more

Tony S. K. Mok, BMSc, MD

on: February 19, 2018In: Names & News
Tony S. K. Mok, BMSc, MD

Posted: February 2018 Tony S. K. Mok, BMSc, MD, has been elected to an International Oncologist seat of the 2019-2020 ASCO Board of Directors. Dr. Mok is the Li Shu […] Read more

John V. Heymach, MD, PhD

on: February 19, 2018In: Names & News
John V. Heymach, MD, PhD

Posted: February 2018 John V. Heymach, MD, PhD, has been named a Fellow (Medical Sciences) of the American Association for the Advancement of Science (AAAS). Dr. Heymach is the Chair […] Read more

Yasushi Yatabe, MD, PhD

on: December 19, 2017In: Names & News
Yasushi Yatabe, MD, PhD

Posted: December 2017 Yasushi Yatabe, MD, PhD, is the recipient of the 2017 IASLC Mary J. Matthews Pathology/Translational Research Award. Dr. Yatabe has served as Chief of the Department of […] Read more

Ramon Rami-Porta, MD, PhD

on: December 19, 2017In: Names & News
Ramon Rami-Porta, MD, PhD

Posted: December 2017 Ramón Rami-Porta, MD, PhD, is the recipient of the 2017 IASLC Merit Award. Dr. Rami-Porta was appointed this year as the Clinical Chief of the Department of […] Read more

«‹78910111213›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy